Clinical Trials Browser

OTHER × Adenocarcinoma × Leuprolide × Clear all

NCT07444983 2026-03-03

Rezvilutamide for High-Risk Prostate Cancer After Surgery

Phase NA Not yet recruiting

Adenocarcinoma, Prostatic Neoplasms